Stamm

Stämm is a San Francisco-based biomanufacturing company that develops advanced bioprocessing platforms inspired by laminar flow in nature. The company's High-throughput Bioprocessor miniaturizes an entire biotech facility into a compact, plug-and-play desktop unit, enabling biologics production, cell line development, and cell therapy manufacturing at a fraction of traditional scale. Stämm also offers bioengineering services for clinical and commercial cell line development, and a Bio AI platform that builds cell-predictive pipelines using multi-omics data and generative AI models. Founded in 2016 by Yuyo Llamazares Vegh and Federico D'Alvia Vegh, the company operates across the US, Argentina, and Switzerland.